CClinicalTrials.gg
CompletedNCT05762757Updated Sep 19, 2024

Patient-centered Educational Material to Improve Colposcopy Adherence

An interventional study of Colposcopy educational material in Cervical Cancer Screening, sponsored by Washington University School of Medicine. Completed at 1 site in United States. Open to female participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
21 Years and older
Sex
Female
01

Study summary

The long-term goal is to develop, test, and disseminate a social needs navigator intervention that improves colposcopy adherence. Based on stakeholder feedback, this study addresses the need to include patient-centered educational material to the navigator program in order to improve patients' health literacy regarding cervical cancer prevention.

Read the detailed description

The investigators will evaluate the effectiveness of the colposcopy educational material. The investigators aim to recruit 25 newly referred colposcopy patients before their appointment, ask them to take a 5-minute test about their knowledge of colposcopy, have them view an online demo of the educational resources, and then retake the test.

02

Conditions studied

  • Cervical Cancer Screening

Keywords

  • cervical cancer screening
  • colposcopy
  • patient education
03

In context

Uterine Cervical Neoplasms

1,881 studies on the registry are indexed under Uterine Cervical Neoplasms; 567 are open to participants now.

This study's enrollment of 25 is below the median of 100 across 1,377 interventional studies indexed under Uterine Cervical Neoplasms.

Browse Uterine Cervical Neoplasms studies →

Lead sponsor

Washington University School of Medicine is the lead sponsor of 1,765 studies on the registry; 271 are open to participants now.

Of its 324 completed or terminated interventional studies of FDA-regulated products, 212 (65%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Age 21 years or older
  • Abnormal cervical screen confirmed by cytology or pathology
  • Referred to Washington University School of Medicine (WUSM) colposcopy clinic

Exclusion criteria

Exclusion Criteria:

  • History of cervical cancer
  • Unable to consent
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    Colposcopy educational material

    Participants will complete a 9-question quiz that will assess knowledge of colposcopy. They will then view the colposcopy educational material and answer the same 9-question quiz to assess their knowledge of colposcopy. Participants will complete the Acceptability Intervention Measure, the Intervention Appropriateness Measure, and the Feasibility of Intervention Measure. Participants will also be asked whether the educational material influences their intention to adhere to colposcopy.

    Other: Colposcopy educational material

Interventions

  • OtherColposcopy educational material

    -Will consist of a handout featuring education and information regarding colposcopies.

06

What researchers measure

Primary outcomes

  1. Change in participant knowledge of colposcopy

    -9 question questionnaire that will assess patient knowledge of colposcopy

    Time frame: Prior to viewing educational material and after viewing educational material (Day 1)

Secondary outcomes

  1. Acceptability of educational material as measured by the Acceptability of Intervention Measure

    This is a 4-item measure of perceived intervention acceptability. Items are measured on a 5-point Likert scale (Completely disagree-completely agree). Mean score is calculated.

    Time frame: Day 1

  2. Appropriateness of educational material as measured by the Intervention Appropriateness Measure

    This is a 4-item measure of perceived intervention appropriateness. Items are measured on a 5-point Likert scale (Completely disagree-completely agree). Mean score is calculated.

    Time frame: Day 1

  3. Feasibility of educational material as measured by the Feasibility of Intervention Measure

    Time frame: Day 1

  4. Number of participants who stated that the educational material will influence their intention to adhere to colposcopy

    This is a 4-item measure of perceived intervention feasibility. Items are measured on a 5-point Likert scale (Completely disagree-completely agree). Mean score is calculated.

    Time frame: Day 1

07

Study locations

1 site
  • Washington University School of Medicine
    Saint Louis, Missouri 63110, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05762757
Lead sponsor
Washington University School of Medicine
Collaborators
American Association of Obstetricians and Gynecologists
Responsible party
Sponsor
First posted
Mar 10, 2023
Start date
Jan 30, 2024
Primary completion
Sep 6, 2024
Completion
Sep 6, 2024
Last update
Sep 19, 2024

Study contacts

Lindsay M Kuroki, M.D.
principal investigator · Washington University School of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion